CD4+ T-cell Subsets in Inflammatory Diseases: Beyond the Th1/Th2 Paradigm
Overview
Authors
Affiliations
CD4(+)T cells are crucial for directing appropriate immune responses during host defense and for the pathogenesis of inflammatory diseases. In addition to the classical biphasic model of differentiation of T-helper 1 (Th1) and Th2 cells, unexpected increases in the numbers of CD4(+)T-cell subsets, including Th17, Th9, T follicular-helper (Tfh) and T-regulatory (Treg) cells, have been recognized. In the present review, we focus on how these various T-helper cell subsets contribute to the pathogenesis of immune-mediated inflammatory diseases. In particular, we focus on multiple sclerosis, psoriasis and asthma as typical model diseases in which multiple T-helper cell subsets have recently been suggested to play a role. We will also discuss various unique sub-populations of T-helper cells that have been identified. First, we will introduce the heterogeneous T-helper cell subsets, which are classified by their simultaneous expression of multiple key transcription factors. We will also introduce different kinds of memory-type Th2 cells, which are involved in the pathogenesis of chronic type-2 immune-related diseases. Finally, we will discuss the molecular mechanisms underlying the generation of the plasticity and heterogeneity of T-helper cell subsets. The latest progress in the study of T-helper cell subsets has forced us to reconsider the etiology of immune-mediated inflammatory diseases beyond the model based on the Th1/Th2 balance. To this end, we propose another model--the pathogenic T-helper population disease-induction model--as a possible mechanism for the induction and/or persistence of immune-mediated inflammatory diseases.
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis.
Yue N, Zhao H, Hu P, Zhang Y, Tian C, Kong C J Nanobiotechnology. 2025; 23(1):65.
PMID: 39891249 PMC: 11783912. DOI: 10.1186/s12951-025-03158-8.
Yin J, Liao Y, Liu S, Che B, Zhu H, Yang B Front Immunol. 2025; 15():1381158.
PMID: 39840051 PMC: 11747796. DOI: 10.3389/fimmu.2024.1381158.
Vereertbrugghen A, Pizzano M, Cernutto A, Sabbione F, Keitelman I, Aguilar D Proc Natl Acad Sci U S A. 2024; 121(48):e2407648121.
PMID: 39560641 PMC: 11621630. DOI: 10.1073/pnas.2407648121.
Mangoni A, Zinellu A Clin Exp Med. 2024; 25(1):4.
PMID: 39535678 PMC: 11561007. DOI: 10.1007/s10238-024-01519-5.
Brain temperature, brain metabolites, and immune system phenotypes in temporal lobe epilepsy.
Mueller C, Hong H, Sharma A, Qin H, Benveniste E, Szaflarski J Epilepsia Open. 2024; 9(6):2454-2466.
PMID: 39470707 PMC: 11633690. DOI: 10.1002/epi4.13082.